bioAffinity Technologies to Report Third Quarter 2022 Financial Results San Antonio, TX

Technologies to Report Third Quarter 2022

Antonio, TX - Nov. 8, 2022 - bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) today announced that the Company will

host a conference call and audio webcast on Monday, Nov. 14, 2022, at 8 a.m. ET to discuss its corporate and financial results for the

third quarter of 2022.

audio webcast will be accessible via the Investor Relations section of the Company's website, https://ir.bioaffinitytech.com/.

An archive of the webcast will be available for 90 days.

interested participants and investors may access the conference call by dialing one of the numbers below and entering Conference ID BIAFQ322:

bioAffinity Technologies, Inc.

Technologies, Inc. (NASDAQ: BIAF; BIAFW) addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung,

and targeted cancer treatment. The Company's first product, CyPath Lung, is a non-invasive test that has shown

high sensitivity and specificity for the detection of early-stage lung cancer. Precision Pathology Services licensed and developed CyPath

Lung as a Laboratory Developed Test (LDT) and has begun test marketing in Southeast Texas. OncoSelect Therapeutics,

LLC, a subsidiary of bioAffinity Technologies, is advancing its discoveries shown in vitro to kill cancer cells without harm to

normal cells. Research and optimization of the Company's platform technologies are conducted in its laboratories at The University

of Texas at San Antonio.

press release contains forward-looking statements, including statements regarding the anticipated use of proceeds from the Company's

offering of common shares. Forward-looking statements can be identified by words such as "believes," "expects,"

"estimates," "intends," "may," "plans," "will" and similar expressions, or

the negative of these words. Such forward-looking statements are based on facts and conditions as they exist at the time such statements

are made and predictions as to future facts and conditions. Readers of this press release are cautioned not to place undue reliance on

any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statement relating to matters

discussed in this press release, except as may be required by applicable securities laws.

Maria Zannes, President & Chief Executive Officer

Tiberend Strategic Advisors, Inc.